These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11574648)

  • 1. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.
    Moher D; Schulz KF; Altman DG;
    J Am Podiatr Med Assoc; 2001 Sep; 91(8):437-42. PubMed ID: 11574648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.
    Moher D; Schulz KF; Altman DG
    Lancet; 2001 Apr; 357(9263):1191-4. PubMed ID: 11323066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001.
    Moher D; Schulz KF; Altman D;
    Explore (NY); 2005 Jan; 1(1):40-5. PubMed ID: 16791967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.
    Moher D; Schulz KF; Altman DG;
    Clin Oral Investig; 2003 Mar; 7(1):2-7. PubMed ID: 12673431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.
    Moher D; Schulz KF; Altman DG;
    Ann Intern Med; 2001 Apr; 134(8):657-62. PubMed ID: 11304106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.
    Moher D; Schulz KF; Altman D;
    JAMA; 2001 Apr; 285(15):1987-91. PubMed ID: 11308435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials.
    Moher D; Schulz KF; Altman DG;
    BMC Med Res Methodol; 2001; 1():2. PubMed ID: 11336663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    Int J Surg; 2012; 10(1):28-55. PubMed ID: 22036893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    J Clin Epidemiol; 2010 Aug; 63(8):e1-37. PubMed ID: 20346624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration].
    Hopewel S; Clarke M; Moher D; Wager E; Middleton P; Altman DG; Schulz KF; The CG
    Zhong Xi Yi Jie He Xue Bao; 2008 Mar; 6(3):221-32. PubMed ID: 18334138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.
    Piaggio G; Elbourne DR; Altman DG; Pocock SJ; Evans SJ;
    JAMA; 2006 Mar; 295(10):1152-60. PubMed ID: 16522836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The revised CONSORT statement for reporting randomized trials: explanation and elaboration.
    Altman DG; Schulz KF; Moher D; Egger M; Davidoff F; Elbourne D; Gøtzsche PC; Lang T;
    Ann Intern Med; 2001 Apr; 134(8):663-94. PubMed ID: 11304107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):295-309. PubMed ID: 18283207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better reporting of harms in randomized trials: an extension of the CONSORT statement.
    Ioannidis JP; Evans SJ; Gøtzsche PC; O'Neill RT; Altman DG; Schulz K; Moher D;
    Ann Intern Med; 2004 Nov; 141(10):781-8. PubMed ID: 15545678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration.
    Hopewell S; Clarke M; Moher D; Wager E; Middleton P; Altman DG; Schulz KF;
    PLoS Med; 2008 Jan; 5(1):e20. PubMed ID: 18215107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Randomized clinical trials (CONSORT)].
    Cobos-Carbó A;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():21-7. PubMed ID: 16464423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The CONSORT statement (CONsolidated Standards Of Reporting Trials)].
    Lorette G; Maruani A
    Ann Dermatol Venereol; 2013; 140(6-7):431-5. PubMed ID: 23773740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the reporting of pragmatic trials: an extension of the CONSORT statement.
    Zwarenstein M; Treweek S; Gagnier JJ; Altman DG; Tunis S; Haynes B; Oxman AD; Moher D; ;
    BMJ; 2008 Nov; 337():a2390. PubMed ID: 19001484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CONSORT 2010 statement: extension checklist for reporting within person randomised trials.
    Pandis N; Chung B; Scherer RW; Elbourne D; Altman DG
    Br J Dermatol; 2019 Mar; 180(3):534-552. PubMed ID: 30609010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement.
    Juszczak E; Altman DG; Hopewell S; Schulz K
    JAMA; 2019 Apr; 321(16):1610-1620. PubMed ID: 31012939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.